Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice

Dear Colleagues,

Breast cancer is the leading cause of cancer in women and the second most common cause of cancer death. Radiotherapy is one of the pillars of breast cancer treatment. It is an exciting time in breast cancer radiotherapy, where the landscapes for diagnosis, treatment and prognosis are rapidly evolving. You are invited to contribute to this Special Issue of JCM entitled “Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice”.

Molecular biology is impacting the breast cancer treatment with the development of prognostic gene expression signatures. In early breast cancer, the eligibility criteria for the omission of post-lumpectomy radiotherapy are expanding, while hypofractionation has impacted standard practice and is being actively explored in locally advanced disease; its extension to ultrahypofractionation is revolutionizing treatment schemes. The indications for postmastectomy radiotherapy are actively evolving, while subsets of breast cancer patients with oligometastatic disease, suitable for ablative radiotherapy, are actively being sought.

We look forward to receiving your submissions to this Special Issue.

Prof. Dr. Michael J. McKay
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.